India has overtaken the US on clinical trials but struggles with regulation
Key Points
India overtook the US in clinical trials due to its large patient population and infrastructure advancements.
Concerns arise over unethical practices in the expanding clinical trial sector, affecting credibility and safety.
A growing healthcare infrastructure plays a crucial role in attracting global clinical trials despite regulatory issues.
Regulatory frameworks may need enhancement to ensure ethical standards in India's clinical trial landscape.
Abstract
India’s vast patient population and growing healthcare infrastructure has seen it overtake the US as a go-to for clinical trials. But unethical practices worry doctors as the sector expands, writes Neha Bhatt